Casdin Capital, LLC Gilead Sciences, Inc. Call Options Transaction History

Casdin Capital, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $12.3 Million - $13.6 Million	200,000 New	200,000 $13 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $3.03 Million - $3.95 Million	-50,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $3.56 Million - $3.95 Million	50,000 New	50,000 $3.86 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.